Abstract
BackgroundCheckpoint inhibitors towards cytotoxic T-lymphocyte protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have paved the way for a new frontier of anti-cancer therapies that modulate our pre-existing...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have